Thursday 22 September 2011

Official Opening

Video Surgery

Chairs: José M Enriquez-Navascues (Spain), Paul Antoine Lehur (France)

• ETAR (Endoscopic Trans Anal Resection) technique - Alex Kartheuser (Belgium)
• Natural orifice proctectomy with total mesorectal excision using transanal port and laparoscopic assistance - Francis Michot (France)
• Robotic TME - Daniel Langer (Czech Republic)
• Rectovaginal fistula: martius flap revisited - Katalin Kalmar, Shahram Ghotb Sajjadi, Ors Peter Horvarth (Hungary)

• Transperineal rectocele repair with porcine dermal collagen implant - Giovanni Milito (Italy)
• Rectovaginal fistula after ileoanal pouch in UC - Julio Leite (Portugal)
• Laparoscopic ventral recto-colpo-pexy for rectal prolapse - Marcos Rodrigues Martin (Spain)
• One-instrument laparoscopic colon resection with end-to-end bonding anastomosis - Sergii Podpriatov (Ukraine)

Clinical Trials Update

Chairs: Søren Laurberg (Denmark), James Hill (UK)

Guest speaker: James Hill (UK) - ColoRectal Endoscopic Stenting Trial (CReST)

A session featuring the best selection of submitted trials abstracts

Keynote Lecture: Antiplatelet and anticoagulation agents and colorectal surgery

Speaker: Jørn Dalsgaard Nielsen (Denmark)

Chair: Ronan O'Connell (Ireland)

The Six Best and Visiting Fellow Free Papers

Chairs: Freddy Penninckx (Belgium) - ESCP President, Zoran Krivokapic (Serbia) - ESCP President Elect

• Japanese Visiting Fellow free paper
• ASCRS Visiting Fellow free paper

The Six Best ESCP free papers:

• B1 Intraoperative complications of laparoscopic colorectal resections: Did we get better? - Patryk Kambakamba (Switzerland)
• B2 Influence of two policies of closure of the laparotomy wound upon the incidence of incisional surgical site infection in colorectal cancer surgery. Results of a randomised trial - Eloy Espin (Spain)
• B3 Electroacupuncture for postoperative ileus after laparoscopic colorectal surgery: a randomized sham-controlled study - Simon Ng (Hong Kong)
• B4 Does overt rectal prolapse always need a surgical treatment? - Laurent Siproudhis (France)
• B5 Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial - Wilhelm Graf (Sweden)
• B6 Does R1 resection compromise local control after conservative surgery for low rectal cancer? - Christophe Laurent (France)

Symposium: Neoadjuvant therapy for rectal cancer

Chairs: Mariana Behro (USA), Werner Hohenberger (Germany)

• Tumour response assessment after chemoradiation - Rodrigo Perez (Brazil)
• Which regimen gives best results? - Torbjörn Holm (Sweden)
• Long term outcome of the Dutch and CRO7 trials - Cornelis van de Velde (The Netherlands)

Keynote Lecture: Colorectal GIST

Speaker: Bruno Cola (Italy)

Chair: Mirko Omejc (Slovenia)

Award: Best of the Six Best Papers

This award is supported by the British Journal of Surgery

Free Papers (main auditorium)

Chairs: Peter Dawson (UK), Marek Szczepkowski (Poland)

• F1 Long-term results intraoperative pelvic hyperthermic chemotherapy for the locally advanced rectal carcinoma - Mikhail Alekseev (Russia)
• F2 Defunctioning stoma and leak rate after total mesorectal excision with colo-anal anastomosis in the context of a national project - Freddy Penninckx (Belgium)
• F3 How do postoperative mortality ‘outlier’ institutions for colorectal cancer surgery perform on other measures of quality? - Alex M. Almoudaris (UK)
• F4 Higher frequency of anastomotic leakage in stapled compared to hand-sewn ileocolic anastomoses in a large population-based study - Pia Jestin (Sweden)
• F5 Risk factors, prevalence and incidence of colorectal peritoneal carcinomatosis - a population-based study - Josefin Segelman (Sweden)
• F6 Specific pattern of Volatile Organic Compounds (VOCs) identifies colorectal cancer patients. A new potential screening test - Donato Francesco Altomare (Italy)
• F7 What is a safe distal resection margin in rectal cancer? - Tor E. Bernstein (Norway)
• F8 Macroscopic and Morphometric Quality Assessment for Colonic Cancer: Comparison between Open and Laparoscopic Approach - Nikolaos Gouvas (Greece)
• F9 CEA and MUC2 mRNA in lymph nodes are predictors of outcome in colorectal cancer - Gudrun Lindmark (Sweden)

Free Papers (parallel auditorium)

Chairs: David Waldron (Ireland), Milon Breberina (Serbia)

• F10 Accuracy of Preoperative Magnetic Resonance Imaging in Prediction of Pathological Stage in Rectal Cancer: node-for-node matched histologic validation of MRI imaging features - Jun Seok Park (Republic of Korea)
• F11 Angiogenic response to surgery in patients after curative colon cancer resection and its correlation with oncological results on long term follow up - Marta Pascual (Spain)
• F12 Characterisation of endoluminal tumour deposits (ETDs) may expand rectal conserving alternatives to empirical radical surgery in rectal cancer undergoing neoadjuvant chemoradiotherapy - Fraser Smith (Ireland)
• F13 The treatment of rectal prolapse in 2011; an international survey - Henk A. Formijne Jonkers (The Netherlands)
• F14 Monitoring of internal anal sphincter innervation in patients undergoing total mesorectal excision and early functional outcome - Daniel W Kauff (Germany)
• F15 Sacral Nerve Stimulation reduces Rectal Barrier Permeability in a Preclinical Porcine Model - Claire Blanchard (France)
• F16 Randomized Controlled Trial of Alpha Blocker for Prevention of Acute Voiding Dysfunction After Rectal Cancer Surgery - Sung-Bum Kang (Republic of Korea)
• F17 Autologous Cultured Adipose-derived Stem Cell for the Treatment of Crohn’s Fistula - Chang Sik Yu (Republic of Korea)
• F18 Comparison between patients with perforating and not-perforating Crohn’s disease of the terminal ileum in a surgical population - Igors Iesalnieks (Germany)